EUCTR2005-002411-25-IT进行中（未招募）不适用
CLINICAL PROTOCOL A PROSPECTIVE MULTICENTER, PARALLEL GROUP STUDY WITH A SINGLE BLIND PHASE AND A DOUBLE BLIND RANDOMISED PHASE, TO EVALUATE THE EFFICACY AND SATISFACTION OF VIAGRA (SILDENAFIL CITRATE) HIGH DOSE (100MG) TITRATION COMPARED WITH 50MG DOSE, IN MEN WITH ERECTILE DYSFUNCTIO
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- PFIZER
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
CLINICAL PROTOCOL FOR A MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF A SINGLE DOSAGE OF PARODOXIB SODIUM IV VS. A SINGLE DOSE OF KETOPROPHENE IV VS. ONE UNIQUE DOSAGE OF KETOROLACO IV VS. PLACEBO FOR THE TREATMENT OF PAIN AFTER A LAPAROSCOPIC COLLECISECTOMY.PER-077-02PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
Unknown
不适用
Registry of anti-cancer treatment response prediction tool, CANscript, to understand its use in clinics and impact on the patient treatment outcome.CTRI/2018/12/016813Mitra RxDx India Pvt Ltd
进行中（未招募）
不适用
AN OPEN-LABEL, MULTI-CENTER CONTROLLED CLINICAL TRIAL OF ECULIZUMAB IN ADULT PATIENTS WITH PLASMA THERAPY-RESISTANT ATYPICAL HEMOLYTIC-UREMIC SYNDROME (AHUS)Adult patients with plasma therapy-resistant Atypical Hemolytic-UremicSyndrome (aHUS)MedDRA version: 9.1Level: LLTClassification code 10018932Term: Haemolytic uraemic syndromeEUCTR2008-006952-23-SEALEXION PHARMACEUTICALS, INC.8
进行中（未招募）
不适用
AN OPEN-LABEL, MULTI-CENTER CONTROLLED CLINICAL TRIAL OF ECULIZUMAB IN ADOLESCENT PATIENTS WITH PLASMA THERAPYSENSITIVE ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) - NDEUCTR2008-006955-28-ITALEXION PHARMACEUTICALS15
进行中（未招募）
不适用
AN OPEN-LABEL, MULTI-CENTER CONTROLLED CLINICAL TRIAL OF ECULIZUMAB IN ADOLESCENT PATIENTS WITH PLASMA THERAPYRESISTANT ATYPICAL HEMOLYTIC-UREMIC SYNDROME (AHUS) - NDAdolescent patients (from 12 and up to 18 years of age) with plasma therapyresistant Atypical Hemolytic-Uremic Syndrome (aHUS).MedDRA version: 12.1Level: LLTClassification code 10018933Term: Haemolytic-uraemic syndromeEUCTR2008-006953-41-ITALEXION PHARMACEUTICALS7